Development of a Mimotope-Based Vaccine Against CD20 Antigen

Author(s): Meng Li, Wei Han, Quiyang Zhang, Xiaochang Xue, Zenglu Wang, Yingqi Zhang.

Journal Name: Protein & Peptide Letters

Volume 14 , Issue 6 , 2007

Become EABM
Become Reviewer


CD20, a B-cell-specific protein, is a primary target for immunotherapy of B-cell lymphomas. We used a mimotopes of CD20 to construct vaccines for B-cell-related disorders. The immunogenicity of the vaccines was tested in BALB/c mice. Results of this study suggest that the mimotope may be a useful tool for the construction of a functional vaccine to treat B cell-related disorders.

Keywords: CD20, mimotope, vaccine, B-cell lymphoma, immunotherapy, keyhole limpet hemocyanin (KLH)

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [610 - 614]
Pages: 5
DOI: 10.2174/092986607780989958
Price: $65

Article Metrics

PDF: 4